SG Americas Securities »

Mineralys Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Mineralys Therapeutics

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 2025100k150k200k250k10k15k20k
Value ($)Share countHistorical MLYS position of SG Americas Securities Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2024-12-31 $246k 20k 12.32
2024-09-30 $110k 9.1k 12.07
2023-12-31 $87k 10k 8.62

More positions owned by SG Americas Securities

Apple (AAPL)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Palo Alto Networks (PANW)
UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Royal Caribbean Cruises (RCL)
Invesco Qqq Trust Series 1 (QQQ)
Tesla Opt Call Option
Spdr S&p 500 Etf (SPY)
SPDR Gold Trust (GLD)
MasterCard Incorporated (MA)
SPDR S&P MidCap 400 ETF (MDY)

View all positions for SG Americas Securities

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics